Literature DB >> 32189308

Serum Albumin, Lipid and Drug Binding.

Koji Nishi1, Keishi Yamasaki1,2, Masaki Otagiri3,4.   

Abstract

Albumin is widely conserved from vertebrates to invertebrates, and nature of mammalian albumins permit them to bind various endogenous ligands and drugs in the blood. It is known that at least two major ligand binding sites are present on the albumin molecule, which are referred to as Site I and Site II. These binding sites are thought to be almost completely conserved among mammals, even though the degree of binding to these sites are different depending on the physical and chemical properties of drugs and differences in the microenvironment in the binding pockets. In addition, the binding sites for medium and long-chain fatty acids are also well conserved among mammals, and it is considered that there are at least seven binding sites, including Site I and Site II. These bindings properties of albumin in the blood are also widely known to be important for transporting drugs and fatty acids to various tissues. It can therefore be concluded that albumin is one of the most important serum proteins for various ligands, and information on human albumin can be very useful in predicting the ligand binding properties of the albumin of other vertebrates.

Entities:  

Keywords:  Albumin; Binding site; Drug binding; Fatty acid; Ligand transport

Mesh:

Substances:

Year:  2020        PMID: 32189308     DOI: 10.1007/978-3-030-41769-7_15

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  2 in total

1.  Associations between Milk Fatty Acid Profile and Body Condition Score, Ultrasound Hepatic Measurements and Blood Metabolites in Holstein Cows.

Authors:  Diana Giannuzzi; Alessandro Toscano; Sara Pegolo; Luigi Gallo; Franco Tagliapietra; Marcello Mele; Andrea Minuti; Erminio Trevisi; Paolo Ajmone Marsan; Stefano Schiavon; Alessio Cecchinato
Journal:  Animals (Basel)       Date:  2022-05-06       Impact factor: 3.231

2.  Immunoassay of Glomalin by Quartz Crystal Microbalance Biosensor Containing Iron Oxide Nanoparticles.

Authors:  Miroslav Pohanka; Vitezslav Vlcek
Journal:  Int J Anal Chem       Date:  2020-09-01       Impact factor: 1.885

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.